Accelerating Progress in Pediatric Cancer
NCI is pushing the “bench to bedside” paradigm to bring medical advances into the clinic.
Pediatric cancers are considered rare diseases, which makes them more challenging to study and treat. However, efforts like the Childhood Cancer Data Initiative are helping to further disease biology understanding and open pathways for community collaboration. In light of Childhood Cancer Awareness Month, NCI experts discuss the future of advancements such as precision medicine and immunotherapy.
-
Dr. Nirali Shah Hematologic Malignancies Section Head, Pediatric Oncology NCI -
Dr. Christine Heske Translational Sarcoma Biology Group Head, Pediatric Oncology NCI
-
Coast Guard Poised for Growth in Cyber
The service’s prevention policy chief discusses his priorities for combatting cyber incidents that could have global impacts.
23m listen -
How VA is Using Digital Services to Expand Care to Veterans
CIO Kurt DelBene says the the agency’s 2024 priorities included AI adoption, hiring and a better user experience for veterans.
30m listen -
Cancer HealthCast: This Unique Network Closes Research Gaps in Cancer Genomics
In this episode, Dr. Leah Mechanic, Program Director at NCI and Dr. Bettina Drake, Professor at Washington University School of Medicine
24m listen -
HealthCast: Indian Health Service's Modernization Journey Means Replacing HHS’s Oldest Legacy System
Indian Health Service CIO Mitchell Thornbrugh joins HealthCast to talk about ways that IHS is progressing in its modernization program and the need for a patient-centered, human-centered approach to care.
26m listen
